Accueil>>Signaling Pathways>> Neuroscience>> Histamine Receptor>>Diphenhydramine HCl

Diphenhydramine HCl (Synonyms: DPH)

Catalog No.GC10445

Le chlorhydrate de diphenhydramine est un antagoniste des récepteurs H1 de l'histamine de première génération À effet anticholinergique.

Products are for research use only. Not for human use. We do not sell to patients.

Diphenhydramine HCl Chemical Structure

Cas No.: 147-24-0

Taille Prix Stock Qté
10mM (in 1mL DMSO)
36,00 $US
En stock
50mg
50,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Diphenhydramine hydrochloride, a histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations.Target: Histamine H1 receptorDiphenhydramine hydrochloride, a histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects. Diphenhydramine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding.

References:
[1]. Benadryl. From Wikipedia, the free encyclopedia

Avis

Review for Diphenhydramine HCl

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Diphenhydramine HCl

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.